Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 57 | 01.01.13 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 19.09.22 |
Chief Operating Officer | 57 | 20.10.14 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 04.12.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 24.09.15 |
Chairman | 74 | 01.01.11 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 04.05.17 |
Director/Board Member | 63 | 15.05.18 | |
Eva Idén
BRD | Director/Board Member | 58 | 04.05.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 10 | 453 283 | 0 | 0 | 87,87 % |
Aktie B | 1 | 13 018 137 | 11 837 506 ( 90,93 %) | 0 |
Unternehmenskontakt
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Pharmaceuticals: Major
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+15.54% | 78.51 Mrd. | |
+12.05% | 9 Mrd. | |
+58.17% | 4.96 Mrd. | |
-14.94% | 4.84 Mrd. | |
-.--% | 3.72 Mrd. | |
+21.94% | 2.48 Mrd. | |
-26.63% | 2.19 Mrd. | |
+16.75% | 2.12 Mrd. | |
-37.97% | 1.94 Mrd. |